Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow enhancements. JENA, (Germany), SHANGHAI, (China), | 27 ...

JPMorgan analyst Anchal Verma adjusted the price target on Carl Zeiss Meditec AG (AFX:GR) (OTC: CZMWY) to €41.00, up from the previous €40.00, while maintaining an Underweight rating on the stock. The ...

Shares of Carl Zeiss Meditec AG (ETR:AFX) dropped 6% today after the company reported its first-quarter revenues, which showed a slight increase of 1.2% versus the Vara consensus but were coupled with ...

Nevertheless, we were able to post slight growth thanks to the DORC acquisition. The good response to the new products, the approval of our VISUMAX ® 800 refractive laser system for the Chinese market ...

Despite revenue growth and strategic advancements, Carl Zeiss Meditec AG (CZMWF) faces margin pressures and market uncertainties, particularly in China.

ZEISS Medical Technology announced today that the National Medical Products Administration (NMPA) in China has approved the ...

The device offers a shortened procedure time and efficient, effective SMILE for patients with myopia, with or without ...